The advanced 2D C-arm imaging technology used by the system develops an accurate map of the patient's spine

Caduceus-S-AR-1

Surglasses reports first AR surgery in the US with its Caduceus S AR Spine Navigation System. (Credit: Taiwan Main Orthopaedic Biotechnology Co., Ltd.)

Surglasses/Caduceus S (Surglasses) from Taiwan Main Orthopaedic Biotechnology has announced the completion of the first augmented reality (AR) surgery in the US with the Caduceus S AR Spine Navigation System using 2D C-Arm Imaging.

Caduceus S is said to be an AR spine navigation system that needs only a few-shots of C-arm images to power surgeons with AR and pre-surgical planning with trajectories for spine surgery.

According to Taiwan Main Orthopaedic Biotechnology, the advanced 2D C-arm imaging technology used by the system develops an accurate map of the patient’s spine.

The company claimed that the surgery marks a significant milestone and breakthrough in the field of spinal surgery in the US. It was performed by Dr Sherwin Hua at Stevenson Surgery Center in California.

Taiwan Main Orthopaedic Biotechnology said that the AR technology will enable the surgical team to view the patient’s anatomy in real-time with overlay information. This will offer more accuracy and detail.

The team used the Caduceus S AR Spine Navigation System to navigate the patient’s spine with precision and accuracy, said the company.

The firm claimed that this allowed the surgery team to take informed decisions and perform the surgery with greater efficiency and confidence and thus improving the outcome for the patient.

The company stated: “The successful completion of the first augmented reality surgery using the Caduceus S AR Spine Navigation System is a testament to Surglasses’ commitment to advancing medical technology and improving patient outcomes.

“As the technology continues to evolve, it is clear that this system will play an increasingly significant role in the future of spinal surgery.”

In December last year, Surglasses secured the US Food and Drug Administration 510(k) approval for the navigation System. The firm plans to introduce the product in the US market in the first quarter of this year.